NEUROONE MEDICAL TECHNOLOGIES Corp (NASDAQ:NMTC)
| Market Cap | $5.94M-83.7% |
| Revenue (ttm) | $10.00M+50.8% |
| Net Income | -$7.15M-34.0% |
| EPS | -$0.91-151.8% |
| Shares Out | 9.11M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 98,475 |
| Open | $0.64 |
| Previous Close | $0.67 |
| Day's Range | $0.63 - $0.67 |
| 52-Week Range | $0.61 - $6.12 |
| Beta | 0.64 |
| Analysts | Buy |
| Price Target | $5.00(+666.75%) |
| Earnings Date | Dec 15, 2026 |
About NMTC
NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of electroencephalograms (cEEG) and stereoelectroencephalograms (sEEG), as well as therapeutic interventions including spinal cord stimulation, brain stimulation, and ablation procedures. The technology aims to assist individuals afflicted by conditions like epilepsy, Parkinson's disease, dystonia, essential tremors, persistent pain arising from unsuccessful back surgeries, and a variety of other neurological disorders. Furthermore, the company has forged a crucial partnership with RBC Medical Innovations to engineer a radio frequency ablation generator. This generator is designed to integrate seamlessly with NeuroOne's unique dual-function electrode, allowing for both the precise monitoring of brain electrical activity and the targeted ablation of brain tissue using a singular instrument. The corporate headquarters are situated in Eden Prairie, Minnesota.
NEUROONE MEDICAL TECHNOLOGIES Corp Stock Analysis — InsiderScore
NEUROONE MEDICAL TECHNOLOGIES Corp scored higher than 19% of companies evaluated by InsiderBuying, and ranked 40th out of 47 stocks in the healthcare sector.
Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.
Insiders at NEUROONE MEDICAL TECHNOLOGIES Corp bought $67.0K of stock across 1 purchase in the last 90 days, the largest of them $67.0K.
The average purchase added about 20% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.
Every buyer already held stock, so each purchase is an increase rather than a first position.
This category carries 35% of the Insider Score.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Next catalysts
- Dec 15, 2026Earnings report
$NMTC stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in NMTC holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by NMTC's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
NMTC Estimated quarterly lobbying spending
Source: U.S. Senate LDA
NMTC Revenue by Segment
| Upfront payment | $3.00M | 20.04% |
| Aggregate transaction price | $3.00M | 20.04% |
| Fee payment | $3.00M | 20.04% |
| License revenue | $3.00M | 20.04% |
| Product revenue | $1.97M | 13.18% |
| Additional payment | $1.00M | 6.68% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New NMTC patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to NMTC from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in NMTC
| VTIVanguard Morningstar Total Stock Market ETF | $186.27K |
| VXFVanguard Extended Market ETF | $83.56K |
| IWCiShares Micro-Cap ETF | $13.89K |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from NMTC’s recent data — informational, not investment advice
What’s Behind the Score
Recent Insider Activity
Insider Score Trend Over Time
+10.5 since Sep 21Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
